Riskpilot← Back to searchSign inGet full accessROMERIKE HJERTESENTER AS
ASActiveOrg 915287050Dampsagveien 4, 2000 LillestrømMedical specialists activities · NACE 8622Est. 20156 employees
Revenue 2024
NOK 5,5M
-2% vs 2023
EBITDA margin
-0.1%
-104% vs 2023
Equity ratio
-1.1%
Financial strength
Net profit 2024
NOK -20K
-73% vs 2023
| Revenue | NOK 5,5M | -2% |
| EBITDA | NOK -3K | -104% |
| Net profit | NOK -20K | -73% |
| Total assets | NOK 943K | +34% |
| Equity | NOK -10K | -207% |
| Employees | 6 | — |
Legal name
ROMERIKE HJERTESENTER AS
Org number
915287050
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
23. april 2015
Share capital
NOK 50 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Drive kontorfellesskap for spesialistlegetjenester og helsetjenester, formidling av slike tjenester samt forretningsdrift av enhver art, kjøp, salg av aksjer og verdipapirer, samt hva hermed står i forbindelse, herunder å delta i andre selskaper, innen- og utenlands med lignende forretningsvirksomhet som formål.
Address
Dampsagveien 4, 2000 Lillestrøm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 630 | 5 005 | 5 171 | 5 659 | 5 541 |
| Staff expenses | −2 564 | −2 884 | −2 978 | −3 116 | −3 067 |
| EBITDA | 25 | 92 | 94 | 92 | −3 |
| Depreciation & amort. | −27 | −92 | −96 | −94 | −6 |
| EBIT | −2 | −0 | −2 | −2 | −9 |
| Net financials | 2 | 0 | 2 | 2 | 11 |
| Profit before tax | 0 | −0 | −0 | −0 | 2 |
| Tax | 1 | 2 | 10 | 12 | 22 |
| Net profit | −1 | −2 | −10 | −12 | −20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 547 | 1 053 | 826 | 702 | 943 |
| Equity | 33 | 31 | 21 | 10 | −10 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 513 | 1 022 | 804 | 692 | 954 |
| Total debt | 514 | 1 022 | 804 | 692 | 954 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20202024
Equity ratio
-1.1%
This company
38.2%
Market median
-103% vs market
20202024
Return on equity
-1997100.0%
This company
18.4%
Market median
-10853904% vs market
20202024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20202024
Asset turnover
5.87×
This company
1.12×
Market median
+424% vs market
20202024
Debt / equity
92.22×
This company
0.62×
Market median
-14774% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JG Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Malta Holding As
ROMERIKE HJERTESENTER AS Board members of ROMERIKE HJERTESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Glasø | Chief Executive Officer | 0 companies |
| Julita Karpinska | Chairman | 0 companies |